S Barath
Overview
Explore the profile of S Barath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Friberg M, Behndig A, Bosson J, Muala A, Barath S, Dove R, et al.
Part Fibre Toxicol
. 2023 Dec;
20(1):47.
PMID: 38062420
Background: Diesel exhaust (DE) induces neutrophilia and lymphocytosis in experimentally exposed humans. These responses occur in parallel to nuclear migration of NF-κB and c-Jun, activation of mitogen activated protein kinases...
2.
Hajdu K, Kapitany A, Dajnoki Z, Soltesz L, Barath S, Hendrik Z, et al.
J Eur Acad Dermatol Venereol
. 2020 Nov;
35(6):1357-1361.
PMID: 33131126
Background: Allergen immunotherapy (AIT) is considered a curative treatment in some atopic diseases, but in AD contradictory clinical results exist and the action of AIT has not been elucidated. In...
3.
Biro B, Szabo R, Illesy L, Balazsfalvi N, Szollosi G, Barath S, et al.
Transplant Proc
. 2019 May;
51(4):1234-1238.
PMID: 31101204
Background: New-onset diabetes mellitus after transplant (NODAT) is a well-known complication of renal transplant that severely affects graft and patient survival. It is necessary to explore further risk factors and...
4.
Sujai G, Triveni V, Barath S, Harikishan G
J Pharm Bioallied Sci
. 2015 Nov;
7(Suppl 2):S656-9.
PMID: 26538938
Introduction: The purpose of study was twofold: To determine the extent of inter valuator and inter group variation in risk scores assigned to study subjects by PRC and PRA. To...
5.
Barath S, Triveni V, Sujai G, Harikishan G
J Pharm Bioallied Sci
. 2015 Nov;
7(Suppl 2):S600-6.
PMID: 26538927
Objective: The purpose of this prospective, randomized, double-blind study was to compare the anesthetic efficacy of 2% mepivacaine and 2% lidocaine (both with 1:80,000 epinephrine) for inferior alveolar nerve block...
6.
Hajas A, Barath S, Szodoray P, Nakken B, Gogolak P, Szekanecz Z, et al.
Hum Immunol
. 2013 Apr;
74(7):833-41.
PMID: 23608739
Mixed connective tissue disease (MCTD) is a systemic autoimmune disorder, characterized by the presence of antibodies to U1-RNP protein. We aimed to determine phenotypic abnormalities of peripheral B cell subsets...
7.
Gyimesi E, Gonczi F, Szilasi M, Pal G, Barath S, Sipka S
Inflamm Res
. 2012 Oct;
62(2):213-8.
PMID: 23109053
Objective: We tested the effect of various doses of bacterial lipopolysaccharide (LPS, endotoxin) on the expression of CD63 and the in vitro release of histamine by basophils stimulated with ragweed...
8.
Griger Z, Toth B, Barath S, Gyetvai A, Kovacs I, Tarr T, et al.
Scand J Immunol
. 2011 Oct;
75(2):243-8.
PMID: 21988336
The effects of proteosome inhibitor Bortezomib (BZ) were studied in vitro for 24 h on the protein kinase C (PKC) profiles, rates of proliferation and apoptosis in Jurkat cells and...
9.
Szodoray P, Varoczy L, Papp G, Barath S, Nakken B, Szegedi G, et al.
Scand J Rheumatol
. 2011 Sep;
41(2):110-5.
PMID: 21936606
Objective: High-dose chemotherapy followed by autologous haematopoietic stem cell transplantation (AHSCT) can be a salvage therapy for patients with severe, refractory systemic autoimmune diseases. The function of the newly rebuilt...
10.
Papp G, Horvath I, Barath S, Gyimesi E, Sipka S, Szodoray P, et al.
Scand J Rheumatol
. 2011 Mar;
40(3):205-10.
PMID: 21366383
Objectives: The aim of this study was to evaluate a wide spectrum of peripheral immune-competent cell types, reflecting overall disturbances in immune homeostasis, characteristic of systemic sclerosis (SSc). We also...